Jubilant Pharmova
JUBLPHARMANSE

Jubilant Pharmova

₹819.853.30 (0.40%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
800.05
Today’s high
820.55
52 week low
786.05
52 week high
1,248.00
Open price
815.00
Previous close
816.55
Live volume
47,195
Lower circuit
653.25
Upper circuit
979.85

Fundamentals

Market Cap
₹13,006Cr
ROE
7.25%
P/E Ratio(TTM)
30.28
EPS(TTM)
26.96
P/B Ratio
1.97
Dividend Yield
0.61%
Industry P/E
31.44
Book Value
413.79
Debt to Equity
0.44
Face Value
1

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Jubilant Pharmova Limited is an integrated global pharmaceutical firm engaged in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Generics, and Proprietary Novel Drugs businesses. Relying on strategic planning and disciplined execution, the company confidently navigates the pharmaceutical landscape to drive growth and success in global markets. The company believes in delivering its promise of 'Caring, Sharing, and Growing,' enhancing value for customers and stakeholders through innovation and wise investment. A key business involves manufacturing and supplying Radiopharmaceuticals through a network of 46 radiopharmacies located across the United States. Its Allergy Immunotherapy business manufactures and supplies allergic extracts and venom products to the US and other key markets like Canada, Europe, and Australia. In fiscal year 2024, the company's consolidated revenue from operations grew by 7% to ₹67,029 million, with EBITDA increasing by 20% to ₹9,936 million.;
MD/CEO
Mr. Priyavrat Bhartia
Founded in
1978
NSE symbol
JUBLPHARMA
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
47.68%
Retail And Others
25.14%
Foreign Institutions
15.96%
Mutual Funds
7.69%
Other Domestic Institutions
3.54%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹7,745.00
-107.00 (1.36%)
L
    H
    19,631.8897.7224.57
    ₹1,302.10
    -8.10 (0.62%)
    L
      H
      18,171.9838.65.17
      Natco PharmaNATCOPHARM
      ₹1,014.20
      +12.30 (1.23%)
      L
        H
        17,944.1211.542.07
        ₹617.30
        -10.80 (1.72%)
        L
          H
          15,244.4527.943.83
          Livesquawk
          Jubilant Pharmova's Q3 EBITDA rose to ₹2.9B from ₹2.87B YoY. EBITDA margin declined to 13.6% from 15.8% YoY.
          Livesquawk
          Jubilant Pharmova appoints Mr. Daniel J. O'Connor as CEO of Jubilant Therapeutics.
          2026
          6
          Feb
          Quarterly Result
          Release date
          2025
          31
          Oct
          Quarterly Result
          Release date
          29
          Jul
          Quarterly Result
          Release date

          25
          Jul
          Dividend
          Ex date
          ₹5.00
          per share

          For each share you hold, you will receive ₹5.00
          Dividend amount₹5.00 per share
          Dividend TypeFinal
          Ex Date25 Jul ‘25
          Record Date25 Jul ‘25
          Announcement date16 May ‘25

          16
          May
          Dividend
          Announced
          ₹5.00
          per share

          For each share you hold, you will receive ₹5.00
          Dividend amount₹5.00 per share
          Dividend TypeFinal
          Ex Date25 Jul ‘25
          Record Date25 Jul ‘25
          Announcement date16 May ‘25
          2024

          2
          Aug
          Dividend
          Ex date
          ₹5.00
          per share

          For each share you hold, you will receive ₹5.00
          Dividend amount₹5.00 per share
          Dividend TypeFinal
          Ex Date2 Aug ‘24
          Record Date2 Aug ‘24
          Announcement date29 May ‘24

          29
          May
          Dividend
          Announced
          ₹5.00
          per share

          For each share you hold, you will receive ₹5.00
          Dividend amount₹5.00 per share
          Dividend TypeFinal
          Ex Date2 Aug ‘24
          Record Date2 Aug ‘24
          Announcement date29 May ‘24
          Events calendar
          View upcoming events in other stocks